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Introduction
Neurosurgeons are commonly faced with cranial vault 
defects. These often result from trauma in the form of skull 
fractures leading to bone loss or decompressive craniectomies 
to control raised intracranial pressure. Tumour infiltration into 
bone leads to excised bone being discarded as is the case in 
sepsis and osteitis which requires extensive debridement. 
Several strategies exist to manage these defects. Saving 
the patient’s own bone and replacing it at a later stage as an 
autologous cranioplasty is the preferred method. This can be 
achieved by storing the patient’s bone in an appropriate bone 
freezer, or even storing it in a subcutaneous pouch created in 
the patient’s abdomen.1,2  
When replacing the patient’s own bone is impossible, 
alternate strategies to close the cranial defects include covering 
the defect with a wide variety of materials such as titanium 
mesh, polymethyl methacrylate (PMMA) or hydroxyapatite.3 
The challenges posed by these materials involve the expense 
of the material, sepsis risk, thermal injury to the brain and 
cosmetic defects when the original skull contours are not 
achieved.
PMMA or bone cement, as it is known in the orthopaedic 
realm, is readily available and cost effective and thus an 
attractive option to fill cranial vault defects. PMMA is an 
acrylic polymer created when two sterile components (a 
powder and a liquid) are mixed. A paste is formed and over 
the course of a few minutes will solidify. An exothermic 
reaction takes place during the curing of the polymer and can 
reach up to 86 ᵒC.4 While the polymer sets, it can be moulded 
into a specific shape.5 Once hardened and cooled, it is safe 
for implant into humans.5,6 The exothermic curing process of 
the PMMA poses a challenge for use in cranioplasty as the 
paste cannot be held against the cranial defect to mould due to 
risk of thermal injury to the brain.2 The extreme temperatures 
also create difficulty in handling the paste, often leading to 
unsatisfactory cosmetic results. 
The solution to this involves creating patient specific 
implants by using a computed tomogram (CT) 3-dimensional 
(3D) reconstruction of the defect.3,4 These implants are 
manufactured specific to the defect and from a myriad of 
materials of which titanium and PMMA are the most popular. 
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In the South African market, limited access to these exist and 
therefore most implants are imported which leads to greater 
expense and increased turn-around time. Other international 
institutions identified these challenges and circumvented them 
by using the craniotomy bone intraoperatively to create a 
mirror implant with PMMA at the time of initial surgery, store 
it and autoclave when ready for implant.5,6 This approach, 
however, becomes impractical in a high trauma environment 
where it is difficult to predict who will eventually require 
cranioplasty.
A locally manufactured patient-specific custom-made 
silicone mould was pioneered at the Department of 
Neurosurgery at Tygerberg Academic Hospital in 2008. It 
involves creating a silicon mould as a negative of the desired 
implant based on a 3D reconstructed image of the defect, 
which can be autoclaved. This provides the surgeon with 
the opportunity to create the custom made implant in theatre 
under sterile conditions during the cranioplasty procedure. 
A further advantage is to create a 3D printed model of the 
skull preoperatively, plan the surgery and craniotomy defect 
(often in tumour surgery) and create a template to draw out 
the proposed craniotomy during live surgery, as well as create 
the implant mould of the planned defect. This allows for 
immediate reconstruction during surgery, should it have been 
anticipated that the bone be discarded (see Figures 4,5,6).
The aim of this study is to perform a pro- and retrospective 
review of 60 locally manufactured patient specific moulds. 
The primary objective will be to assess the practicality, safety 
and cost effectiveness of the moulds and to compare the 
results to existing products and techniques. Specific outcome 
measures include cost, cosmesis and sepsis rates compared to 
the existing body of knowledge.
Ethical approval for this study was obtained from the Health 
Research Ethics Committee at the University of Stellenbosch 
under the number S13/08/143.
Materials and methods
A total of 30 consecutive patients were included in the 
prospective leg of the study that required custom made cranial 
implants at Tygerberg Academic Hospital in the Western Cape 
Province of South Africa.
The data collected included primary pathology, patient 
demographics, duration between pathology and cranioplasty, 
surgical and postoperative complications, efficacy and 
accuracy of the implant, intraoperative detail and patient 
satisfaction (dissatisfied, neutral or satisfied). 
The retrospective review studied 30 patients for implant 
accuracy and complications. 
Septic complications were classified as superficial or deep. 
The custom-made silicon moulds were made by 
Craniotech®, a locally based company specialised in patient 
specific cranial reconstruction and 3D printing solutions (See 
Figures 1, 2 and 4).
The silicon mould is autoclaved just prior to the procedure 
and presented to the surgeon once the defect is exposed. Dural 
edges are freed until the full thickness of the skull surrounding 
the defect is appreciated. PMMA is mixed and placed in the 
mould. After it has set and cooled, minor trimming of the 
graft is done and secured in place with cranial fixators and/or 
miniplates. Prophylactic antibiotics are given routinely prior 
Figure 1: A two piece custom silicon mould that can be 
autoclaved.
Figure 2: PMMA is mixed and placed in the mould.
Figure 3: A custom implant. Excess PMMA is easily trimmed.
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to the first incision. The defect is routinely closed in available 
layers.
The primary outcome was described by means of proportion 
of patients with a specific complication (with 95% Confidence 
Intervals indicating population estimates).
Numeric data has been described using means (with 
Standard Deviations) or medians (with Interquartile range) if 
the data is skewed.
Results 
Between 2010 and 2016, 60 patients underwent PMMA 
cranioplasty using a custom-made silicon mould. All 
patients had their implants produced intraoperatively using 
the templated moulding system. Thirty of these patients 
were analysed retrospectively and 30 consecutive cases 
prospectively. 
All grafts were fitted into the defect without manipulation 
resulting in a 100% planning to implant ratio.
In the retrospective group, no septic complications were 
noted. One patient had an implant that displaced (too few 
fixation points resulting in swivelling) and in another an 
extradural hematoma was evacuated. This patient fell in the 
ward thus the hematoma was likely unrelated to the implant 
or procedure.
In the prospective group, patient demographic included 
24 males and 6 females with a mean age of 31.9 years. 
Trauma was the most common cause of cranial vault defect 
(23 out of 30 patients) with 18 decompressive craniotomies. 
Five patients had emergency surgery for skull fractures that 
were contaminated and compromised bone was removed. 
Four patients had surgery to remove meningiomas. Of these, 
one extended intraosseously which was not appreciated 
preoperatively, two developed sepsis of the autologous bone 
Figure 4: Pre-surgical planning of an intraosseous meningioma. A planned craniotomy is done on the 3D model.
Figure 5: A planning template of the craniotomy is made and 
used intraoperatively to guide the actual craniotomy.
Figure 6: By using the planning template, a custom made 
silicon mould for the implant already existed and the defect 
closed with a cosmetically accurate implant.
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immediately postoperatively and in one the bone was left off 
to control intracranial pressure. One patient presented with 
a subdural empyema with the bone left off and 2 developed 
wound sepsis after autologous bone was replaced for non-
traumatic hematomas.
Cranioplasty was performed no sooner than 4 months after 
the initial surgery.
Sepsis
In total there were 5 infective complications resulting in 
an overall sepsis rate of 8.3%. The pathogen involved in 
four of the cases was Staphylococcus Aureus with Group B 
haemolytic Streptococci being identified in one case. 
All septic cases had superficial wound breakdown. No new 
osteitis was noted at the graft sites. There were no cases of 
deep seated infection. Of the 5 septic complications, 4 had 
initial primary septic pathologies (1 subdural empyema, 
3 septic autologous bone flaps) and 1 was a meningioma. Two 
patients with sepsis had their implants removed due to leakage 
of cerebrospinal fluid from a dural breach. 
There was no statistical significance between age, gender, 
time to surgery and sepsis rate, nor was there correlation 
between intraoperative blood loss or size and site of the 
craniotomy to sepsis rate. 
Cosmesis and Patient Satisfaction
With regards to patient satisfaction, a three-point patient 
satisfaction scale was utilised. Twenty-three patients were 
satisfied, 2 were dissatisfied and 2 were neutral. Three patients 
were lost to follow-up. There was no correlation between age, 
gender and patient satisfaction. The two patients who were 
dissatisfied both developed septic complications. 
Cost
The average cost of a moulded PMMA implant was at least 
5 times cheaper than available similar products. 
Discussion
The current public health service is overrun by the 
extensive trauma burden it faces on a day to day basis with 
trauma proving to be a massive challenge in the surgical 
environment.7 It poses a great challenge for cosmetic surgery 
when life-threatening conditions constantly invade surgical 
lists. Furthermore, should cosmetic type cases be done, 
elevated costs further add to them not being performed.
A cost-effective option exists in the form of PMMA which 
is widely used as bone cement in orthopaedic surgery.8 The 
challenges with attempting to create a cranioplasty implant by 
dealing directly with the PMMA paste is the different stages of 
hardening. Initially the paste is too soft and sticky to mould, 
and once the hardening effect is taking place, the heat element 
makes handling and shaping the implant very challenging 
with temperatures of up to 86°C reached.8 Numerous factors 
such as thickness of the graft, accurate interface with the 
defect edges and curvature play an extremely important role 
in ultimate cosmetic success.
The solution is to create a custom made implant based on a 
3-dimensional reconstruction of the bony defect. This would 
meet the abovementioned criteria yet this could cost up to 
R200 000 per implant depending on the material with the 
cheapest options being around R75 000.
Significant cost-saving is achieved with the studied method 
of creating a custom silicon mould which is the negative of 
the desired implant that can be autoclaved in theatre.  This 
gives the surgeon the ability to create a sterile implant (using 
PMMA) that perfectly matches the defect in all parameters. 
The mould has one or two so-called exhaust ports where 
excess PMMA can run off when the mould is compressed. 
This requires minor trimming of the graft prior to placement.
The study population was largely traumatic in nature and 
often when assaulted the patients’ skin and underlying tissues 
are compromised which is a sepsis risk. Sepsis in cranioplasty 
is a well-known complication. Kwarcinski et al. in their 
meta-analysis of materials, manufacturing techniques and 
infection risk demonstrated an overall sepsis rate of 6.99% in 
pre-manufactured PMMA implants, 10.98% in hand-formed 
PMMA implants and 6.86% in templated PMMA implants.10 
This was comparable with titanium mesh and plates which had 
7.71% and 8.31% average reported infection rates. Infection 
risk was higher in cases which had previous infection or 
previous revision surgery.10 
In our study, two cases of sepsis resulted from cerebrospinal 
fluid leakage causing superficial wound breakdown. One, on 
revision, was noted to be due to ingrowth of the temporal 
muscle into the dural patch of the previous surgery, and 
the other iatrogenic when the edges of the craniotomy site 
were freed from scar tissue and the dural defect not noted 
intraoperatively. One of the advantages of the silicon mould is 
the ability to re-use it if necessary as the mould is simply re-
sterilised in theatre and a new PMMA implant created.
When dealing with previous craniotomy sites, care has to be 
taken when closing the wound with surgical clips as this can 
lead to subtle infolding of the wound edges pre-disposing it 
to sepsis. Closure of a previous site is recommended in these 
scenarios with Nylon. Fixation of the implant to the free bony 
edges can utilise any fixation devices but requires a minimum 
of 3 fixation points to prevent swivelling of the implant.
The use in delayed cranioplasty has proven to be very 
successful. A further use is in planning of cases where 
significant cranioplasty is anticipated. The preoperative 3D 
reconstructed skull is printed and the craniotomy planned 
on the model. A template is created to use as a guide for the 
craniotomy (sterilised in theatre) with a pre-determined mould 
ready to prepare the implant with. This creates a perfect 
cosmetic result and avoids further surgery (see Figures 4, 5 
and 6).
Conclusion
Patient specific moulds using PMMA to create custom 
implants are safe, have excellent cosmetic results and are a 
very cost-effective option to manage cranial defects. Accurate 
planning strategies for large craniotomies, where bone will 
potentially be discarded, add to surgical effectiveness and cost 
saving to the patient.
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